Neuroimaging Methods for MRI Analysis in CSF Biomarkers Studies.

Area of Science:

• Neuroscience
• Biomarkers
• Medical Imaging

Background:

• Alzheimer's disease (AD) is increasingly viewed as a continuum, with pathophysiological biomarkers like cerebrospinal fluid (CSF) Aβ-42, t-tau, and p-tau detectable before symptom onset.
• Magnetic resonance imaging (MRI) allows in vivo study of structural and functional changes over time.

Purpose of the Study:

• To describe neuroimaging methods for integrating CSF metabolite data with imaging analyses.
• To facilitate a synergistic approach for understanding structural correlates of AD biomarkers.

Main Methods:

• Detailed description of neuroimaging techniques.
• Methodologies for combining CSF metabolite measurements with MRI data.
• Analysis of structural and functional correlates.

Main Results:

• The integration of CSF biomarkers and MRI data provides a comprehensive view of AD pathophysiology.
• This combined approach enhances the understanding of structural changes associated with specific AD biomarkers.
• The described methods enable researchers to correlate biochemical changes with in vivo imaging findings.

Conclusions:

• Combining CSF biomarker analysis with neuroimaging offers a powerful, synergistic approach to studying Alzheimer's disease.
• This integrated methodology is crucial for advancing our understanding of AD as a continuum.
• The described neuroimaging methods are essential for researchers investigating the structural underpinnings of AD biomarkers.